Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q1 2023 Earnings Call Transcript
Juli Miller: Good morning, and welcome to Adaptimmune's conference call to discuss our first quarter 2023 financial results and business updates.
Source: insidermonkey.com
Stay updated with breaking news from First Quarter Call. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Juli Miller: Good morning, and welcome to Adaptimmune's conference call to discuss our first quarter 2023 financial results and business updates.